Terms: = Liver cancer AND BCL9, LGS, 607, ENSG00000116128, MGC131591 AND Clinical Outcome
1 results:
1. Early onset of hypertension and serum electrolyte changes as potential predictive factors of activity in advanced HCC patients treated with sorafenib: results from a retrospective analysis of the HCC-AVR group.
Casadei Gardini A; Scarpi E; Marisi G; Foschi FG; Donati G; Giampalma E; Faloppi L; Scartozzi M; Silvestris N; Bisulli M; Corbelli J; Gardini A; La Barba G; Veneroni L; Tamberi S; Cascinu S; Frassineti GL
Oncotarget; 2016 Mar; 7(12):15243-51. PubMed ID: 26893366
[TBL] [Abstract] [Full Text] [Related]
